Navigation Links
Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
Date:5/15/2013

SAN DIEGO, May 15, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the first quarter ended March 31, 2013, and reported on highlights and other recent developments including:

  • Awarded ISO 13485 Certification for Excellagen, State of California manufacturing license and state clearances to market and sell Excellagen in the U.S., and advanced other international registrations for Excellagen, including CE Mark registration, which the Company expects to receive approval on or around the end of the second quarter 2013. 
  • Announced sales and distribution agreement with Academy Medical, LLC to market, sell and distribute Excellagen to U.S. government medical providers.  Academy Medical has a growing customer base of over 35 Veterans Administration and military hospitals within the U.S.  Cardium also entered agreements with independent regional distributor groups with sales representatives focused on podiatry, orthopedic physicians, plastic surgeons, hospitals and surgical centers. Including Academy Medical, there are currently over 60 sales representatives selling Excellagen. 
  • Excellagen awarded the American Podiatric Medical Association's Seal of Approval for its contributions to better foot health and mobility.
  • Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting highlighting Excellagen's capability of promoting rapid granulation and complete healing in three difficult and complex post-surgical wounds, including Mohs surgery and wound dehiscence.
  • Presentation at the 2013 Phacilitate Annual Cell & Gene Therapy Forum in Washington, DC, "Optimizing Phase III Trial Design for Generx® (Ad5FGF-4)" reporting on adaptive coronary collateral growth, the biological processes to be targeted by therapeutic angiogenesis, and discussed the lessons
    '/>"/>

  • SOURCE Cardium Therapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Cardium Announces Generx Publication In Molecular Therapy
    2. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
    3. Cardium Presents Year-End 2012 Financial Results And Recent Developments
    4. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
    5. Cardium Receives ISO Certification for Excellagen
    6. Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
    7. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
    8. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
    9. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
    10. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
    11. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/21/2015)... Cardiologists at Henry Ford Hospital have implanted a device that ... heartbeat. With only handful of hospitals in the ... to add another option to its arsenal of tools for ... to pump. "This is a first in ... at a non-clinical trial site," says cardiologist Claudio Schuger ...
    (Date:4/21/2015)... 21, 2015  St. Vincent Healthcare is raising ... Already following strict disinfection routines, St. Vincent Healthcare is ... eliminate harmful germs, like Ebola, methicillin-resistant Staphylococcus ... can infect patients during their hospital stay. ... Logo - http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
    (Date:4/21/2015)... smokers, was selected to present as a finalist at the American Heart Association,s Health Sciences Innovation ... Photo - http://photos.prnewswire.com/prnh/20150421/199989 ... ... ... of all cardiovascular disease is caused by smoking. The IntelliQuit™ device and mobile app ecosystem is ...
    Breaking Medicine Technology:Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 2IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 3
    ... 11, 2011 Conatus Pharmaceuticals Inc. today announced the ... private placement financing.  This financing was led by new ... participation by existing investors; Aberdare Ventures, Advent Venture Partners, ... Fund.  Conatus will use the proceeds to advance the ...
    ... 2011 Stryker Corporation,s (NYSE: SYK ) ... 510(k) clearance for its MDM X3 Modular Dual Mobility ... to the company,s portfolio of next-generation technologies designed to ... and address a broader patient population, including both primary ...
    Cached Medicine Technology:Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing 2Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System 2Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System 3
    (Date:4/21/2015)... 21, 2015 The California Healthcare ... leading life sciences organizations, released the following statement ... California State Assembly Bill (AB) 463: , “As ... the development of treatments and cures for patients ... concerns regarding AB 463, the so-called Pharmaceutical Cost ...
    (Date:4/21/2015)... City, NJ (PRWEB) April 21, 2015 ... collaboration across platforms and devices, today announced a new ... integration of the new Microsoft Office 365 Management Activity ... allows customers to fully audit and take action on ... environments. , “The new Office 365 Management Activity API ...
    (Date:4/21/2015)... 2015 Lowcostcarinsuranceprice.com has released a new blog ... for SUVs. , SUVs are large vehicles that ... an SUV and a smaller regular car shows that passengers ... This makes SUV safer in crashes, but these large vehicles ... situation. , It is now possible to find low ...
    (Date:4/21/2015)... 2015 Carinsurancehints.com has released a new ... their impact on auto insurance prices . ... insurance prices. Clients should review their insurance options before ... bought under several forms. Some of the popular policies ... can compare online rates and find the best prices ...
    (Date:4/21/2015)... CA (PRWEB) April 21, 2015 Respected ... PACS® strategy , Visage Imaging Inc. (“Visage”), ... PME), has signed a seven-year contract with University ... in Northern Florida. The deal furthers the penetration ... hospital space, a key area of the North American ...
    Breaking Medicine News(10 mins):Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3Health News:Auto Insurance Quotes For SUVs Are Available Online 2Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4
    ... By Maureen Salamon HealthDay Reporter , WEDNESDAY, ... improve patient safety, a six-year study at 10 North ... which included medical errors and unavoidable mistakes. ... randomly selected hospital admissions, teams of reviewers found 588 ...
    ... HealthDay Reporter , WEDNESDAY, Nov. 24 (HealthDay ... cancers aren,t diagnosed until the disease is well-advanced and, ... Almost one-half of colorectal cancers and cervical cancers ... are detected at a late stage, according to the ...
    ... light both the promise and the frustration of developing ... of skin cancer. Early clinical tests of a candidate ... results in patients whose cancers resisted all currently available ... invariably returned a few months later, able to withstand ...
    ... , WEDNESDAY, Nov. 24 (HealthDay News) -- A study ... lethal for blacks than it is for whites. In ... nearly one-fifth higher than it is for whites in that ... Office on Smoking and Health at the U.S. Centers for ...
    ... 24 It,s never fun riding the bench but could ... the future? That,s one of the questions being explored by ... Wilfrid Laurier University and the Canada Research Chair in Group Dynamics ... this week,s Canada Research Chairs conference in Toronto. Eys, ...
    ... London, UK, 24 November 2010 Research from ... ( http://www2.i-med.ac.at/psychlab/ ) at the Medical University Innsbruck ... in rats exhibited pathologies similar to Alzheimer,s disease. ... Neuroscience (45(4):408-417, 2010) with lead author Dr. ...
    Cached Medicine News:Health News:Despite Efforts, Study Finds No Decline in Medical Errors 2Health News:Despite Efforts, Study Finds No Decline in Medical Errors 3Health News:Too Many Cancers Still Spotted Too Late: CDC 2Health News:Too Many Cancers Still Spotted Too Late: CDC 3Health News:Researchers shine light on how some melanoma tumors evade drug treatment 2Health News:Researchers shine light on how some melanoma tumors evade drug treatment 3Health News:Black Smokers May Face Higher Death Risk Than Whites: CDC 2Health News:Being a 'good sport' can be critical to maintaining lifelong physical activity 2Health News:Chronic high cholesterol diet produces brain damage 2
    Lyphochek Hemostasis Control is a multi-analyte control to help monitor coagulation factor assays and selected thrombosis risk assays. Assayed values are available for most major instrumentation....
    ... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
    Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
    Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
    Medicine Products: